Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against REGENXBIO Inc. (“REGENXBIO” or the “Company”) (NASDAQ: RGNX).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed